Spotlight on daclizumab: its potential in the treatment of multiple sclerosis
Degenerative Neurological and Neuromuscular Disease · 2016-11 · Volume 6 · 95-109
DOI: 10.2147/dnnd.s85747 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Degenerative Neurological and Neuromuscular Disease, 2016-11. Verfasst von Ron Milo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Barzilai University Medical Center, Ashkelon, Israel, ronm@bmc.gov.il. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Barzilai University Medical Center, Ashkelon, Israel, ronm@bmc.gov.il.
- Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel, ronm@bmc.gov.il.
- Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX.
- Neurology Section, VA North Texas Health Care System, Medical Service, Dallas, TX, USA.
Zitieren
APA
Milo, R., & Stüve, O. (2016). Spotlight on daclizumab: its potential in the treatment of multiple sclerosis. Degenerative Neurological and Neuromuscular Disease, Volume 6, 95-109. https://doi.org/10.2147/dnnd.s85747
Vancouver
Milo R, Stüve O. Spotlight on daclizumab: its potential in the treatment of multiple sclerosis. Degenerative Neurological and Neuromuscular Disease. 2016;Volume 6:95-109. doi:10.2147/dnnd.s85747
BibTeX
@article{Milo2016,
author = {Milo, Ron and Stüve, Olaf},
title = {Spotlight on daclizumab: its potential in the treatment of multiple sclerosis},
journal = {Degenerative Neurological and Neuromuscular Disease},
year = {2016},
volume = {Volume 6},
pages = {95--109},
doi = {10.2147/dnnd.s85747}
}
EUVIMED